Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer

Abstract

TRT after PD-(L)1 inhibitor treatment resulted in significantly increased incidence and severity of treatment-related pneumonitis in patients with lung cancer. Intensive attention should be emphasized to the safety of this sequential combination in clinical practice.